Srinivas N. Pentyala
Direktor/Vorstandsmitglied bei Translational Research Group, Inc.
Profil
Srinivas N.
Pentyala is a Director of Affinimark Technologies, Inc. He is a Faculty Member of Anesthesiology, Urology, Health sciences, Physiology, and Biophysics at the Medical School of the State University of New York.
Dr. Pentyala is a Director for Translational Research.
He is a Course Director for the New York State Center for Biotechnology.
Dr. Pentyala worked as a Professor and Faculty Member at Stony Brook University.
He holds a PhD.
Aktive Positionen von Srinivas N. Pentyala
| Unternehmen | Position | Beginn |
|---|---|---|
| The State University of New York | Corporate Officer/Principal | - |
| Translational Research Group, Inc. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Srinivas N. Pentyala
| Unternehmen | Position | Ende |
|---|---|---|
| Stony Brook University | Corporate Officer/Principal | - |
Affinimark Technologies, Inc.
 Affinimark Technologies, Inc. Medical SpecialtiesHealth Technology Affinimark Technologies, Inc. develops proprietary medical diagnostic products. Its products address lucrative market opportunities and serious unmet medical/surgical needs and its lead product, cerebrostripTM, is a strip-based diagnostic test, derived from affinimark's own cutting edge research that will quickly and cost-effectively provide a definitive determination whether the patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. The company was founded by Harry H. Penner, Jr. and Levesque Christopher in 2007 and is headquartered in New Haven, CT. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Affinimark Technologies, Inc.
Affinimark Technologies, Inc. Medical SpecialtiesHealth Technology Affinimark Technologies, Inc. develops proprietary medical diagnostic products. Its products address lucrative market opportunities and serious unmet medical/surgical needs and its lead product, cerebrostripTM, is a strip-based diagnostic test, derived from affinimark's own cutting edge research that will quickly and cost-effectively provide a definitive determination whether the patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. The company was founded by Harry H. Penner, Jr. and Levesque Christopher in 2007 and is headquartered in New Haven, CT. | Health Technology |
| Translational Research Group, Inc. |